Similar Posts
Supply and safety issues surrounding an H1N1 vaccine/Lancet Editorial
From the Aug 1, 2009 Lancet online: Last week, Australia and the USA announced that they would begin trials of an H1N1 vaccine. Vaccination against H1N1 will be an important development in controlling the impact of the pandemic. However, several thorny issues exist around vaccine manufacture and approval. All countries will require the vaccine but…
A long-term perspective on immunity to COVID/ Nature
https://www.nature.com/articles/d41586-021-01557-z nature news & views article NEWS AND VIEWS 14 June 2021 A long-term perspective on immunity to COVID Determining the duration of protective immunity to infection by SARS-CoV-2 is crucial for understanding and predicting the course of the COVID-19 pandemic. Clinical studies now indicate that immunity will be long-lasting. “The good news is that…
Mandating flu vaccine for health care workers
Although CDC said it would not support mandatory flu vaccinations for healthcare workers (imagine the lawsuits if this were a federal government mandate), various organizations have recently published policy statements* in favor of such mandatory inoculations for all workers in healthcare facilities. What is truly strange about this effort is that you cannot find convincing…
WHO. Dastardly difficult to get info on the IHRs and Treaty. But the members raised WHO’s budget about 30% and reelected Tedros.
Here is what the WHO put out today as news regarding the IHRs. You can see that it is clear as mud. I think the outrage and publicity has slowed the adoption of amendments down, which is very good. Here you can read about the goings on from Alexis Baden-Meyer, the Political Director of Organic…
Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.
This article discusses literally a couple dozen vaccines and drugs that are in development for Ebola. How is their testing being fast-tracked ? BioDrugs. 2013 Dec;27(6):565-83. doi: 10.1007/s40259-013-0046-1. Choi JH1, Croyle MA. Author information Abstract Ebola is a highly virulent pathogen causing severe hemorrhagic fever with a high case fatality rate in humans and non-human primates (NHPs)….
Novartis: We have done no testing for the carcinogenicity of MF59
At the 12/2008 FDA-NIH meeting on how to study novel adjuvants, Novartis scientist (Novartis owns the MF59 adjuvant) Dr. Novicki made the following statement: “Carcinogenicity–we have done no testing for the carcinogenicity of MF59 adjuvant or any of our preventive vaccines. We haven’t done it and we don’t plan to.” (See page 391.) And if…
5 Comments
Comments are closed.
Sorry to hear of your accident. Your blog is a most valuable resource. Feel better soon.
Hope you have a speedy recovery Dr. Nass, thanks for all of your posts, they are greatly appreciated.
Hope you are feeling well soon!
All the best,
Sandy Gottstein
http://www.vaccinationnews.com
God bless you! Take care!
ellen
Your blog has introduced me to you, and waked me up to many things. I wish you a speedy and full recovery! Thanks for being out there.